INTERLEUKIN INHIBITORS
- anakinra (KINERET)
- basiliximab (SIMULECT)
- bimekizumab (BIMZELX)
- brodalumab (SILIQ)
- canakinumab (ILARIS)
- guselkumab (TREMFYA, TREMFYA ONE-PRESS, TREMFYA I.V.)
- ixekizumab (TALTZ)
- mirikizumab (OMVOH, OMVOH)
- risankizumab (SKYRIZI)
- sarilumab (KEVZARA)
- satralizumab (ENSPRYNG)
- secukinumab (COSENTYX)
- siltuximab (SYLVANT)
- spesolimab (SPEVIGO)
- tildrakizumab (ILUMYA)
- tocilizumab (ACTEMRA, AVTOZMA, TYENNE)
- ustekinumab (PYZCHIVA I.V., OTULFI I.V., YESINTEK I.V., STEQEYMA IV, OTULFI, YESINTEK, FINLIUS I.V., STEQEYMA, JAMTEKI I.V., STELARA, FINLIUS, STELARA I.V., WEZLANA I.V., WEZLANA, PYZCHIVA, JAMTEKI)
Using Health Canada Drug Database
updated on 07Oct2026.